Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SECOIA: Percutaneous A1 Pulley Release vs Corticosteroid Injection for Trigger Finger
NCT05045157Active, not recruiting
- Sponsor
- CHD Vendée
- Start
- May 2022
- Primary completion
- May 2026
- Countries
- 1
01
Overview
Randomised trial in trigger finger (2 arms), sponsored by CHD Vendée. Primary endpoint: Complete resolution of trigger finger's symptoms at 1 year. Started May 2022; status: active, not recruiting.
02
Conditions
trigger finger
Beyond the preview
Go deeper on NCT05045157.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05045157.